Accelerating and de-risking CMC development with transposon-derived manufacturing cell lines.
Rajendran S, Balasubramanian S, Webster L, Lee M, Vavilala D, Kulikov N, Choi J, Tang C, Hunter M, Wang R, Kaur H, Karunakaran S, Sitaraman V, Minshull J, Boldog F.
Rajendran S, et al. Among authors: kulikov n.
Biotechnol Bioeng. 2021 Jun;118(6):2301-2311. doi: 10.1002/bit.27742. Epub 2021 Apr 2.
Biotechnol Bioeng. 2021.
PMID: 33704772
Free PMC article.